Cytogen in prostate cancer awareness campaign:
This article was originally published in Clinica
Executive Summary
Cytogen, which develops imaging agents and radioactive seed implants for the diagnosis and treatment of prostate cancer, is launching the second "screen, stage and support" campaign aimed at increasing prostate cancer awareness. The Princeton, New Jersey-based company is participating in a special event at the Nasdaq Market Open, together with representatives from the American Cancer Society. Around one in six men will develop prostate cancer, which is the second leading cause of cancer death among men in the US.